Navigation Links
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
Date:4/20/2012

NEW YORK, April 20, 2012 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Chelsea Therapeutics International, Ltd. ("Chelsea" or the "Company") (Nasdaq: CHTP).   

(Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO )

The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that:  (1) Chelsea's Northera (droxidopa) product, an orally-active synthetic precursor of norepinephrine being developed for the treatment of symptomatic neurogenic orthostatic hypotension, would not receive approval from the U.S. Food and Drug Administration; and (2) the Company's numerous statements regarding the safety and efficacy of the product, as well as reportedly positive results from Northera's clinical trials, were materially false and misleading.

Request more information now by clicking here:  www.faruqilaw.com/CHTP

Take Action
If you purchased Chelsea securities between November 3, 2008 and March 28, 2012 and would like to discuss your legal rights, visit www.faruqilaw.com/CHTP.  You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com or fmcconville@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Chelsea's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential matter.

FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn:  Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Francis McConville, Esq.
fmcconville@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

 


'/>"/>
SOURCE Faruqi & Faruqi, LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP Announces Investigation of ZELTIQ Aesthetics, Inc.
2. Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
3. Faruqi & Faruqi, LLP Announces Investigation of GenVec, Inc.
4. Supreme Court to Decide Overtime Fate for Pharmaceutical "Sales Representatives" -- JacksonWhite, Kingsley & Kingsley and Sanford Wittels & Heisler
5. Frost & Sullivan: Industry Push toward Quantitative Imaging Positions Computer Aided Detection and Diagnosis Adequately for Renewed Clinical Expansion
6. Frost & Sullivan: U.S. Nuclear Medicine and PET Imaging Systems Market Witnessed a Rebound in 2010, With PET Blazing the Trail
7. Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market
8. Talysts CEO is Nominated for the Ernst & Young Entrepreneur of the Year Award
9. R&D Trends: Depression - Clinical attrition driven by mature market conditions
10. Fi Asia-China, Hi & Ni China is Ready for Return on June 2012 in Shanghai
11. PediaVision to Conduct Free Screenings With "Spot" at Kips Bay Boys & Girls Club
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2019)... ... December 06, 2019 , ... The Multiple System Atrophy Coalition ... bold new initiative to kickstart MSA research collaborations. Multiple system atrophy is ... by $3 million in new bequests earmarked for research and combined with ongoing ...
(Date:12/5/2019)... ... December 05, 2019 , ... ... (AWS) Public Sector Partner Program; a designation that will accelerate digital transformation ... collaborates with partners that offer solutions and proven experience delivering on government, ...
(Date:12/5/2019)... SAN FRANCISCO (PRWEB) , ... December 05, 2019 ... ... senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces key issues to ... 11-12, 2020 at the Four Seasons Hotel in San Francisco. ...
Breaking Medicine Technology:
(Date:12/14/2019)... ... ... For two years, the only hospital in the Middle Florida Keys has ... would make you think of the temporary buildings you would see at school growing ... building and the hospital carried on, first in tents and then in these buildings. ...
(Date:12/9/2019)... ... , ... Greenlight Guru, quality management system purpose-built ... Change Management capabilities . The enhanced Change Management capabilities include advanced workflow ... change orders in a collaborative change workspace, while also ensuring connectivity and traceability ...
(Date:12/8/2019)... ... , ... More than 85 million people across the United States currently suffer ... Dermatology, indicating this problem is more common than previously believed. Studies show the numbers ... dermatological conditions vary in type and severity and span all age groups. In response ...
(Date:12/6/2019)... OMAHA, Neb. (PRWEB) , ... December 06, 2019 ... ... staffing and recruiting, has been recognized for excellence in employee learning. The Omaha-based ... , which ranks organizations with the most successful employer-sponsored training and development programs ...
(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... Allegheny Health ... , Dr. Gyure, who joined AHN from WVU Medicine in May 2018, previously served ... She has served as interim chair since October and is also part of the ...
Breaking Medicine News(10 mins):